Chapter 66
Non-operative facial rejuvenation
Jean Carruthers,
Alastair Carruthers,
Jean Carruthers
Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada
Search for more papers by this authorAlastair Carruthers
Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada
Search for more papers by this authorJean Carruthers,
Alastair Carruthers,
Jean Carruthers
Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada
Search for more papers by this authorAlastair Carruthers
Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada
Search for more papers by this authorBook Editor(s):Ross D. Farhadieh BSc(Med)Hons, MBBS, MD, EBOPRASF, FRACS(Plast), FRCS(Plast),
Neil W. Bulstrode BSc(Med)Hons, MBBS, MD, FRCS(Plast),
Sabrina Cugno MD, MSc, FRCSC,
Ross D. Farhadieh BSc(Med)Hons, MBBS, MD, EBOPRASF, FRACS(Plast), FRCS(Plast)
Panthea Plastic Surgery Clinics, Sydney and Canberra, Australia and Australian National University, Canberra, Australia
Search for more papers by this authorNeil W. Bulstrode BSc(Med)Hons, MBBS, MD, FRCS(Plast)
Clinical Lead Plastic Surgery
Great Ormond Street Hospital, London, UK
Search for more papers by this authorSabrina Cugno MD, MSc, FRCSC
Assistant Professor
McGill University, Department of Plastic Surgery, Montreal Children's Hospital, Montreal, Canada
Search for more papers by this authorFirst published: 27 March 2015
Summary
Over the last few decades, a rise in demand for minimally invasive procedures with few side effects and little to no recovery period has led to the emergence of a plethora of products and systems designed to refresh the skin and restore the natural contours of youth. Current approaches to the ageing face include injectables – botulinum toxin and fillers – to diminish the appearance of lines and folds and replace volume lost over the years, as well as techniques designed to initiate fibroplasia and neocollagenesis, such as microdermabrasion, chemical peels, lasers and light- or energy-based devices. Increasingly used in any number of combinations, modern procedures safely and effectively lift and tighten the face and reduce the appearance of wrinkles and surface irregularities with an immediate return to normal activity and a low risk of serious complications.
References
- Shapiro RL, Hatheway C, Swerdlow SL. Botulism in the United States: A clinical and epidemiological review. Annals of Internal Medicine 1998; 129: 221–228.
- Ting PT, Freiman A. The story of Clostridium botulinum: From food poisoning to BOTOX. Clinical Medicine 2004; 4: 258–261.
- Scott AB, Rosenbaum AL, Collins CC. Pharmacologic weakening of extraocular muscles. Investigative Ophthalmology and Visual Science 1973; 12: 924–927.
- Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980; 87: 1044–1049.
- Carruthers A, Carruthers J. Botulinum toxin type A: History and current cosmetic use in the upper face. Seminars in Cutaneous Medicine and Surgery 2001; 20: 71–84.
- Carruthers JDA, Carruthers JA. Treatment of glabellar frown lines with C. botulinum A exotoxin. Journal of Dermatologic Surgery and Oncology 1992; 18: 17–21.
- Borodic GE, Cheney M, McKenna M. Contralateral injections of botulinum A toxin for the treatment of hemifacial spasm to achieve increased facial symmetry. Plastic and Reconstructive Surgery 1992; 90: 972–977.
- Blitzer A, Brin MF, Keen MS, Aviv JE. Botulinum toxin for the treatment of hyperfunctional lines of the face. Archives of Otolaryngology – Head and Neck Surgery 1993; 119: 1018–1022.
- Keen M, Blitzer A, Aviv J, et al. Botulinum toxin A for hyperkinetic facial lines: Results of a double-blind, placebo-controlled study. Plastic and Reconstructive Surgery 1994; 94: 94–99.
- Carruthers A, Carruthers J. History of cosmetic botulinum toxin. In: A Carruthers, J Carruthers, JS Dover, M Alam (eds), Procedures in Cosmetic Dermatology: Botulinum Toxin, pp. 13–17. New York: Saunders Elsevier; 2013.
- Carruthers J, Carruthers A. Botulinum toxin A in the mid and lower face and neck. Dermatology Clinics 2004; 22: 151–158.
- Fagien S, Carruthers JD. A comprehensive review of patient-reported satisfaction with botulinum toxin type a for aesthetic procedures. Plastic and Reconstructive Surgery 2008; 122: 1915–1925.
- Carruthers A, Carruthers J. Eyebrow height after botulinum toxin type A to the glabella. Dermatologic Surgery 2007; 33(1 Spec No.): S26–31.
- Flynn TC, Carruthers JA, Carruthers JA. Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatologic Surgery 2001; 27: 703–708.
- Carruthers A, Carruthers J. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin. Dermatologic Surgery 1998; 24: 1189–1194.
- Liew S, Dart A. Nonsurgical reshaping of the lower face. Aesthetic Surgery Journal 2008; 28: 251–257.
- Carruthers A, Carruthers J. Combination treatment. In: A Carruthers, J Carruthers, JS Dover, M Alam (eds), Procedures in Cosmetic Dermatology: Botulinum Toxin, pp 151–159. New York: Saunders Elsevier; 2013.
- Klein AW. Complications, adverse reactions, and insights with the use of botulinum toxin. Dermatologic Surgery 2003; 29: 549–556.
- Carruthers J, Carruthers A. Complications of botulinum toxin A. Facial Plastic Surgery Clinics of North America 2007; 15: 51–54.
- Coté TR, Mohan AK, Polder JA, Walton MK, Braun MM. Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. Journal of the American Academy of Dermatology 2005; 53: 407–415.
- Neuber F. Fettransplantation. Chirurgie Kongress Verhandlungen der Deutschen Gesellschaft für Chirurgie 1893; 22: 66.
- Kanchwala SK, Bucky LP. Facial fat grafting: The search for predictable results. Facial Plastic Surgery 2003; 19: 137–144.
- Glogau RG, Knott HM. Fillers: evolution, regression, and the future. In: A Carruthers, J Carruthers, JS Dover, M Alam (eds), Procedures in Cosmetic Dermatology: Soft Tissue Augmentation; pp. 3–9. New York: Saunders Elsevier; 2013.
- Cheng JT, Perkins SW, Hamilton MM. Collagen and injectable fillers. Otolaryngologic Clinics of North America 2002; 35: 73–85.
- Sclafani AP, Romo T III. Collagen, human collagen, and fat: The search for a three-dimensional soft tissue filler. Facial Plastic Surgery 2001; 17: 79–85.
- Prather CL. Liquid injectable silicone. In: D Jones (ed.), Injectable Fillers Principles and Practice, pp. 75–90. Chichester, UK: Wiley-Blackwell; 2010.
- Duffy DM. Liquid silicone for soft tissue augmentation. Dermatologic Surgery 2005; 31(11 Pt 2): 1530–1541.
- Narins RS, Beer K. Liquid injectable silicone: A review of its history, immunology, technical considerations, complications, and potential. Plastic and Reconstructive Surgery 2006; 118(Suppl): 77S–84S.
- Orentreich DS, Orentreich N. Injectable fluid silicone. In: R Roenigk, HH Roenigk (eds), Dermatologic Surgery: Principles and Practice, pp. 1349–1395. New York: Marcel Dekker; 1989.
- Duffy DM. Injectable liquid silicone: New perspectives. In: A Klein (ed.), Tissue Augmentation in Clinical Practice: Procedures and Techniques, pp. 237–263. New York: Marcel Dekker; 1998.
- Prather CL, Jones D. Liquid injectable silicone for soft tissue augmentation. Dermatologic Therapy 2006; 19: 159–168.
- Orentreich DS. Liquid injectable silicone: Techniques for soft-tissue augmentation. Clinics in Plastic Surgery 2000; 27: 595–612.
- Chen F, Carruthers A, Humphrey S, Carruthers J. HIV-associated facial lipoatrophy treated with injectable silicone oil: a pilot study. Journal of the American Academy of Dermatology 2013; 69(3): 431–437.
- Jones DH, Carruthers A, Orentreich D, et al. Highly purified 1000-cSt silicone oil for treatment of human immunodeficiency virus-associated facial lipoatrophy. Dermatologic Surgery 2004; 30: 1279–1286.
- Orentreich D, Leone AS. A case of HIV-associated facial lipoatrophy treated with 1000-cs liquid injectable silicone. Dermatologic Surgery 2004; 30(4 Part 1): 548–551.
- Jones D. Approaches to treatment of HIV facial lipoatrophy. Skin Therapy Letter 2005; 10: 5–7.
- Narins RS, Beer K. Liquid injectable silicone: a review of its history, immunology, technical considerations, complications, and potential. Plastic and Reconstructive Surgery 2006; 118(3 Suppl): 77S–84S.
- Hevia O. Six-year experience using 1,000-centistoke silicone oil in 916 patients for soft-tissue augmentation in a private practice setting. Dermatologic Surgery 2009; 35(Suppl 2): 1646–1652.
- Barnett JG, Barnett CR. Treatment of acne scars with liquid silicone injections: 30-year perspective. Dermatologic Surgery 2005; 31(11 Part 2): 1542–1549.
- Moscona AR, Fodor L. A retrospective study on liquid injectable silicone for lip augmentation: Long-term results and patient satisfaction. Journal of Plastic, Reconstructive & Aesthetic Surgery 2010; 63: 1694–1698.
- Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications. Dermatologic Surgery 2003; 29: 573–587.
- Lemperle G, Sadick NS, Knapp TR, Lemperle SM. ArteFill permanent injectable for soft-tissue augmentation: II. Indications and applications. Aesthetic and Plastic Surgery 2010; 34: 273–286.
- Alcalay J, Alkalay R, Gat A, Yorav S. Late-onset granulomatous reaction to Artecoll. Dermatologic Surgery 2003; 29: 859–862.
- Reisberger EM, Landthaler M, Wiest L, Schroder J, Stolz W. Foreign body granulomas caused by polymethylmethacrylate microspheres: successful treatment with allopurinol. Archives of Dermatology 2003; 139: 17–20.
- Kim KJ, Lee HW, Lee MW, Choi JH, Moon KC, Koh JK. Artecoll granuloma: A rare adverse reaction induced by microimplant in the treatment of neck wrinkles. Dermatologic Surgery 2004; 30(4 Part 1): 545–547.
- Carruthers A, Carruthers JD. Polymethylmethacrylate microspheres/collagen as a tissue augmenting agent: Personal experience over 5 years. Dermatologic Surgery 2005; 31(11 Part 2): 1561–1564.
- Conejo-Mir JS, Sanz Guirado S, Angel Muñoz M. Adverse granulomatous reaction to Artecoll treated by intralesional 5-fluorouracil and triamcinolone injections. Dermatologic Surgery 2006; 32: 1079–1081.
- Salles AG, Lotierzo PH, Gemperli R, et al. Complications after polymethylmethacrylate injections: Report of 32 cases. Plastic and Reconstructive Surgery 2008; 121: 1811–1820.
- Hilinski JM, Cohen SR. Soft-tissue augmentation with ArteFill. Facial Plastic Surgery 2009; 25: 114–119.
- Graivier MH, Bass LS, Busso M, Jasin ME, Narins RS, Tzikas TL. Calcium hydroxylapatite (Radiesse) for correction of the mid- and lower face: consensus recommendations. Plastic and Reconstructive Surgery. 2007; 120(6 Suppl): 55S–66S.
- Tzikas TL. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation. Dermatologic Surgery 2008; 34(Suppl 1): S9–15.
- Sklar JA, White SM. Radiance FN: a new soft tissue filler. Dermatologic Surgery 2004; 30: 764–768.
- Tzikas TL. Evaluation of Radiance FN soft tissue filler for facial soft tissue augmentation. Archives of Facial Plastic Surgery 2004; 6: 234–239.
- Busso M, Karlsberg PL. Cheek augmentation and rejuvenation using injectable calcium hydroxylapatite (Radiesse). Cosmetic Dermatology 2006; 19: 583–588.
- Jacovella PF, Peiretti CB, Cunille D, Salzamendi M, Schechtel SA. Long-lasting results with hydroxylapatite (Radiesse) facial filler. Plastic and Reconstructive Surgery 2006; 118(3 Suppl): 15S–21S.
- Jansen DA, Graivier MH. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft tissue augmentation. Plastic and Reconstructive Surgery 2006; 118(Suppl): 22S–30S.
- Silvers SL, Eviatar JA, Echavez MI, Pappas AL. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability. Plastic and Reconstructive Surgery 2006; 118(3 Suppl): 34S–45S.
- Sadick NS, Katz BE, Roy D. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face. Dermatologic Surgery 2007; 33(Suppl 2): S122–126.
- Carruthers A, Carruthers J. Evaluation of injectable calcium hydroxylapatite for the treatment of facial lipoatrophy associated with human immunodeficiency virus. Dermatologic Surgery 2008; 34: 1486–1499.
- Bass LS, Smith S, Busso M, McClaren M. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthetic Surgery Journal 2010; 30: 235–238.
- Sankar V, McGuff HS. Foreign body reaction to calcium hydroxylapatite after lip augmentation. Journal of the American Dental Association 2007; 138: 1093–1096.
- Beer KR. Radiesse nodule of the lips from a distant injection site: Report of a case and consideration of etiology and management. Journal of Drugs in Dermatology 2007; 6: 846–847.
- Sterling JB, Hanke CW. Poly-L-lactic acid as a facial filler. Skin Therapy Letter 2005; 10: 9–11.
- Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. Journal of the American Academy of Dermatology 2005; 52: 233–239.
- Moyle GJ, Brown S, Lysakova L, Barton SE. Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy. HIV Medicine 2006; 7: 181–185.
- Carey DL, Baker D, Rogers GD, et al. A randomized, multicenter, open-label study of poly-L-lactic acid for HIV-1 facial lipoatrophy. Journal of Acquired Immune Deficiency Syndrome 2007; 46: 581–589.
- Hanke CW, Redbord KP. Safety and efficacy of poly-L-lactic acid in HIV lipoatrophy and lipoatrophy of aging. Journal of Drugs in Dermatology 2007; 6: 123–128.
- Beer K. A single-center, open-label study on the use of injectable poly-L-lactic acid for the treatment of moderate to severe scarring from acne or varicella. Dermatologic Surgery 2007; 33(Suppl 2): S159–167.
- Sadove R. Injectable poly-L-lactic acid: a novel sculpting agent for the treatment of dermal fat atrophy after severe acne. Aesthetic and Plastic Surgery 2009; 33: 113–116.
- Salles AG, Lotierzo PH, Gimenez R, Camargo CP, Ferreira MC. Evaluation of the poly-L-lactic acid implant for treatment of the nasolabial fold: 3-year follow-up evaluation. Aesthetic and Plastic Surgery 2008; 32: 753–756.
- Lowe NJ, Maxwell CA, Lowe P, Shah A, Patnaik R. Injectable poly-1-lactic acid: 3 years of aesthetic experience. Dermatologic Surgery 2009; 35(Suppl 1): 344–349.
- Narins RS, Baumann L, Brandt FS, et al. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. Journal of the American Academy of Dermatology 2010; 62: 448–462.
- Palm MD, Woodhall KE, Butterwick KJ, Goldman MP. Cosmetic use of poly-1-lactic acid: a retrospective study of 130 patients. Dermatologic Surgery 2010; 36: 161–170.
- Levy RM, Redbord KP, Hanke CW. Treatment of HIV lipoatrophy and lipoatrophy of aging with poly-L-lactic acid: a prospective 3-year follow-up study. Journal of the American Academy of Dermatology 2008; 59: 923–933.
- Mest DR, Humble GM. Retreatment with injectable poly-1-lactic acid for HIV-associated facial lipoatrophy: 24-month extension of the Blue Pacific study. Dermatologic Surgery 2009; 35(Suppl 1): 350–359.
- Narins RS. Minimizing adverse events associated with poly-L-lactic acid injection. Dermatologic Surgery 2008; 34(Suppl 1): S100–104.
- Reszko AE, Sadick NS, Magro CM, Farber J. Late-onset subcutaneous nodules after poly-L-lactic acid injection. Dermatologic Surgery 2009; 35(Suppl 1): 380–384.
- Wildemore JK, Jones DH. Persistent granulomatous inflammatory response induced by injectable poly-L-lactic acid for HIV lipoatrophy. Dermatologic Surgery 2006; 32: 1407–1409.
- Goldan O, Garbov-Nardini G, Regev E, Orenstein A, Winkler E. Late-onset infections and granuloma formation after facial polylactic acid (New-Fill) injections in women who are heavy smokers. Plastic and Reconstructive Surgery 2008; 121: 336e–338e.
- Alijotas-Reig J, Garcia-Gimenez V, Vilardell-Tarres M. Late-onset immune-mediated adverse effects after poly-L-lactic acid injection in non-HIV patients: clinical findings and long-term follow-up. Dermatology 2009; 219: 303–308.
- Monheit GD, Narins RS, Mariwalla K. NASHA family. In: A Carruthers, J Carruthers, JS Dover, M Alam (eds), Procedures in Cosmetic Dermatology: Soft Tissue Augmentation, pp. 10–16. New York: Saunders Elsevier; 2013.
- Brandt FS, Cazzaniga A. Hyaluronic acid gel fillers in the management of facial aging. Clinical Interventions in Aging 2008; 3: 153–159.
- Jordan D. Soft-tissue fillers for wrinkles, folds and volume augmentation. Canadian Journal of Ophthalmology 2003; 38: 285–288.
- Carruthers J, Cohen SR, Joseph JH, Narins RS, Rubin M. The science and art of dermal fillers for soft-tissue augmentation. Journal of Drugs in Dermatology 2009; 8: 335–350.
- Hirsch RJ, Narurkar V, Carruthers J. Management of injected hyaluronic acid induced Tyndall effects. Lasers in Surgery and Medicine 2006; 38: 202–204.
- Andre P. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA – Q-Medical, Sweden) in European countries: A retrospective study from 1997 to 2001. Journal of the European Academy of Dermatology and Venereology 2004; 18: 422–425.
- Honig JF, Brink U, Korabiowska M. Severe granulomatous allergic tissue reaction after hyaluronic acid injection in the treatment of facial lines and its surgical correction. Journal of Craniofacial Surgery 2003; 14: 197–200.
- Jordan DR. Delayed inflammatory reaction to hyaluronic acid (Restylane). Ophthal Plastic and Reconstructive Surgery 2005; 21: 401–402.
- Mamelak AJ, Katz TM, Goldberg LH, Graves JJ, Kaye VN, Friedman PM. Foreign body reaction to hyaluronic acid filler injection: in search of an etiology. Dermatologic Surgery 2009; 35(Suppl 2): 1701–1703.
- Schanz W, Schippert W, Ulmer A, et al. Arterial embolization caused by injection of hyaluronic acid (Restylane). British Journal of Dermatology 2002; 146: 928–929.
- Peter S, Mennel S. Retinal branch artery occlusion following injection of hyaluronic acid (Restylane). Clinical & Experimental Ophthalmology 2006; 34: 363–364.
- Hirsch RJ, Cohen JL, Carruthers JD. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase. Dermatologic Surgery 2007; 33: 357–360.
- Inoue K, Sato K, Matsumoto D, Gonda K, Yoshimura K. Arterial embolization and skin necrosis of the nasal ala following injection of dermal fillers. Plastic and Reconstructive Surgery 2008; 121: 127e–128e.
- Burt B, Nakra T, Isaacs DK, Goldberg RA. Alar necrosis after facial injection of hyaluronic acid. Plastic and Reconstructive Surgery 2010; 125: 199e–200e.
- Soparkar CN, Patrinely JR, Tschen J. Erasing restylane. Ophthalmic Plastic and Reconstructive Surgery 2004; 20: 317–318.
- Hirsch RJ, Brody HJ, Carruthers JD. Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid. Journal of Cosmetic and Laser Therapy 2007; 9: 182–185.
- Humphrey S, Weiss RA. Reversers. In: Procedures in Cosmetic Dermatology: Soft Tissue Augmentation. . New York: Saunders Elsevier; 2013. pp. 200–7.
- Glashofer MD. Complications of temporary fillers. In: A Carruthers, J Carruthers, JS Dover, M Alam (eds), Procedures in Cosmetic Dermatology: Soft Tissue Augmentation, pp. 179–187. New York: Saunders Elsevier; 2013.
- Prather CL, Wiest LG. Complications of permanent fillers. In: A Carruthers, J Carruthers, JS Dover, M Alam (eds), Procedures in Cosmetic Dermatology: Soft Tissue Augmentation, pp. 188–199. New York: Saunders Elsevier; 2013.
- Spencer JM. Microdermabrasion. American Journal of Clinical Dermatology 2005; 6: 89–92.
- Karimipour DJ, Kang S, Johnson TM, et al. Microdermabrasion with and without aluminum oxide crystal abrasion: a comparative molecular analysis of dermal remodeling. Journal of the American Academy of Dermatology 2006; 54: 405–410.
- Gold MH. Dermabrasion in dermatology. American Journal of Clinical Dermatology 2003; 4: 467–471.
- Coimbra M, Rohrich RJ, Chao J, Brown SA. A prospective controlled assessment of microdermabrasion for damaged skin and fine rhytides. Plastic and Reconstructive Surgery 2004; 113: 1438–1443.
- Shim EK, Barnette D, Hughes K, Greenway HT. Microdermabrasion: A clinicopathologic study. Dermatologic Surgery 2001; 27: 524–530.
- Tan MH, Spencer JM, Pires LM, Ajmeri J, Skover G. The evaluation of aluminum oxide crystal microdermabrasion for photodamage. Dermatologic Surgery 2001; 27: 943–949.
- Lazarus M, Baumann L. Miscellaneous cosmetic products and procedures. In: L Baumann (ed.), Cosmetic Dermatology: Principles and Practice, pp. 117–124. New York: Tata McGraw-Hill; 2003.
- Savardekar P. Microdermabrasion. Indian Journal of Dermatology, Venereology and Leprology 2007; 73: 277–279.
- Goldman A, Wollina U. Facial rejuvenation for middle-aged women: a combined approach with minimally invasive procedures. Clinical Interventions in Aging 2010; 5: 293–299.
- Linder J. Chemical peels and combination therapies. Plastic Surgical Nursing 2013; 33: 88–91.
- Rendon MI, Berson DS, Cohen JL, Roberts WE, Starker I, Wang B. Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing. Journal of Clinical Aesthetic Dermatology 2010; 3: 32–43.
- Bari AU, Iqbal Z, Rahman SB. Tolerance and safety of superficial chemical peeling with salicylic acid in various facial dermatoses. Indian Journal of Dermatology, Venereology and Leprology 2005; 71: 87–90.
- Brody HJ. Variations and comparisons in medium-depth chemical peeling. Journal of Dermatologic Surgery and Oncology 1989; 15: 953–963.
- Monheit GD. The Jessner's + TCA peel: a medium depth chemical peel. Journal of Dermatologic Surgery and Oncology 1989; 15: 945–950.
- Coleman WP III, Futrell JM. The glycolic acid trichloroacetic acid peel. Journal of Dermatologic Surgery and Oncology 1994; 20: 76–80.
- Monheit GD. Chemical peels. Skin Therapy Letter 2004; 9: 6–11.
- Rubin MG. A peeler's thoughts on skin improvement with chemical peels and laser resurfacing. Clinics in Plastic Surgery 1997; 24: 407–409.
